Wearable Cardiac Monitor Patch Market Report 2026

The wearable cardiac monitor patch market size has grown rapidly in recent years. It will grow from $2.04 billion in 2025 to $2.4 billion in 2026 at a compound annual growth rate (CAGR) of 17.5%. The growth in the historic period can be attributed to growing adoption of wearable health monitoring devices, increasing prevalence of cardiovascular diseases, rising need for continuous remote patient monitoring, expansion of home healthcare and telehealth services, and growing focus on early detection of heart abnormalities.

The wearable cardiac monitor patch market size is expected to see rapid growth in the next few years. It will grow to $4.53 billion in 2030 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to increasing integration of wearable cardiac monitor patches with artificial intelligence (AI) analytics, rising demand for noninvasive and long-term heart monitoring, growing adoption of digital health platforms, expansion of connected healthcare infrastructure, and a rise in investment for advanced cardiac diagnostic technologies. Major trends in the forecast period include technology-driven innovations in flexible and skin-friendly wearable sensors, advancements in artificial intelligence (AI)-enabled arrhythmia detection, developments in real-time cloud-based cardiac monitoring systems, rising research and development in miniaturized biomedical devices, and innovation in integrated multimodal vital sign tracking platforms.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the wearable cardiac monitor patch market in the coming years. Cardiovascular diseases are disorders that impact the heart and blood vessels, including conditions such as heart attacks, strokes, and hypertension. The incidence of cardiovascular diseases is rising due to unhealthy lifestyle factors, including poor dietary habits, physical inactivity, and tobacco use. Wearable cardiac monitor patches support cardiovascular disease management by continuously monitoring heart rhythms and identifying abnormalities in real time. They enhance patient outcomes by facilitating early detection, prompt clinical intervention, and personalized treatment strategies. For instance, in October 2024, according to the Centers for Disease Control, a US-based government agency, approximately 919,032 deaths in 2023 were attributed to cardiovascular disease, representing about one in every three deaths. Therefore, the rising prevalence of cardiovascular diseases is fueling the growth of the wearable cardiac monitor patch market.

Major companies operating in the wearable cardiac monitor patch market are focusing on developing advanced products, such as live-stream wearable ECG patches, to improve efficiency, enhance patient care, and reduce manual workload and clinical burden. Live-stream wearable ECG patches are adhesive devices that continuously record and transmit electrocardiogram data in real time, enabling clinicians to remotely monitor a patient’s cardiac activity. For instance, in May 2023, VivaLNK Inc., a US-based digital health and wearable cardiac monitoring company, launched an updated version of its multi-parameter wearable ECG patch. This rechargeable device offers up to 14 days of continuous live-stream monitoring, supporting real-time remote observation and extended monitoring sessions with a single application, thereby reducing demands on both clinicians and patients. It also integrates multi-parameter sensing capabilities, including heart rate variability, respiratory rate, skin temperature, step count, activity level, and posture detection, along with a water-resistant 14-day adhesive, enabling comprehensive remote patient monitoring across use cases such as post-operative care and virtual hospital settings.

In April 2025, HeartcoR Solutions LLC, a US-based provider of ECG core laboratory services, partnered with Wellysis Corp to integrate advanced wearable ECG technologies with centralized clinical expertise, enhancing remote cardiac monitoring capabilities and streamlining data collection for clinical trials and patient care. Through this partnership, HeartcoR Solutions aims to strengthen cardiac safety studies by incorporating Wellysis’ FDA-cleared S-Patch wearable ECG device into clinical trial workflows, improving data accuracy, patient adherence, and overall study outcomes. Wellysis Corp is a South Korea-based digital healthcare company specializing in wearable ECG patch technologies.

Major companies operating in the wearable cardiac monitor patch market are Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Boston Scientific Corporation, ZOLL Medical Corporation, Spire Healthcare Group Plc, iRhythm Technologies Inc., BioTelemetry Inc., Bittium Corporation, AliveCor Inc, Qardio Inc., Sensium Healthcare Ltd., LifeSignals Inc., VivaLNK Inc., Cardiac Insight Inc., Leaf Healthcare Inc., SmartCardia Holdings Ltd., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Bardy Diagnostics Inc., Patch Inc.

North America was the largest region in the wearable cardiac monitor patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the wearable cardiac monitor patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the wearable cardiac monitor patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have impacted the wearable cardiac monitor patches market by increasing costs of imported electronic components, sensors, adhesives, and battery materials. these effects are most evident in continuous monitoring and holter patch segments, particularly in regions such as asia-pacific and north america that depend on global medical device supply chains. higher production costs may influence device pricing and adoption rates, while tariffs are also encouraging localized manufacturing, supplier diversification, and innovation in cost optimized wearable cardiac monitoring solutions, strengthening long term market resilience.

Wearable cardiac monitor patches are adhesive, portable medical devices designed to continuously monitor heart activity, including heart rate and rhythm, over extended periods. They enable real-time cardiac monitoring outside traditional hospital settings, supporting long-term assessment of cardiovascular health. These patches are commonly used to detect arrhythmias, track existing heart conditions, and support remote patient management by transmitting clinically relevant data to healthcare providers. By enabling continuous, non-invasive monitoring, wearable cardiac monitor patches help clinicians make timely, informed decisions and improve overall cardiovascular care and patient outcomes.

The primary product types of wearable cardiac monitor patches are continuous monitoring patches, event monitoring patches, Holter patches, and others. Continuous monitoring patches are wearable cardiac devices designed to provide uninterrupted heart rhythm tracking over extended periods for early detection and management of cardiac abnormalities. These are distributed through online and offline sales, used in applications such as arrhythmia, atrial fibrillation, heart failure, and others, among end users including hospitals and clinics, ambulatory surgical centers, home care settings, and others.

The wearable cardiac monitor patch market consists of revenues earned by entities by providing services such as continuous cardiac rhythm monitoring, remote patient data transmission, real-time arrhythmia detection, clinical data analysis and reporting, and device management and technical support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The wearable cardiac monitor patch market also includes sales of wearable cardiac monitor patches, adhesive cardiac monitoring devices, wireless cardiac telemetry patches, disposable and reusable cardiac monitoring patches, and patch-based heart rhythm monitoring systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.